Cargando…
The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor
Aggressive therapies for patients with metastatic Wilms tumor (WT) with subsequent severe late effects warrant the search for novel therapies. The role of focal adhesion kinase (FAK), a non-receptor tyrosine kinase important in pediatric solid tumor development and progression, has not been examined...
Autores principales: | Aye, Jamie M., Stafman, Laura L., Williams, Adele P., Garner, Evan F., Stewart, Jerry E., Anderson, Joshua C., Mruthyunjayappa, Smitha, Waldrop, Mary G., Goolsby, Caroline D., Markert, Hooper R., Quinn, Colin, Marayati, Raoud, Mroczek-Musulman, Elizabeth, Willey, Christopher D., Yoon, Karina J., Whelan, Kimberly F., Beierle, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756857/ https://www.ncbi.nlm.nih.gov/pubmed/31565187 http://dx.doi.org/10.18632/oncotarget.27165 |
Ejemplares similares
-
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
por: Stafman, Laura L., et al.
Publicado: (2019) -
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
por: Stafman, Laura L., et al.
Publicado: (2019) -
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
por: Garner, Evan F., et al.
Publicado: (2018) -
UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
por: Williams, Adele P., et al.
Publicado: (2019) -
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells()
por: Waters, Alicia M., et al.
Publicado: (2016)